Full Text
Cost-Effectiveness of Dapagliflozin as Add-on to Metformin for the Treatment of Type 2 Diabetes in Greece

Abstract

Authors

C Tzanetakos N Tentolouris G Kourlaba N Maniadakis

Back to Volume 18, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×